ERBB2 and gastric cancer: As shown in Figure 7a, EHF expression was significantly positively correlated with the expression of EGFR (R=0.43; P=0.018), HER2 (R=0.51; P=0.004) and HER3 (R=0.39; P=0.034) in gastric cancers.